Octreotide inj, non-depot
Products billed under this code include Octreotide Acetate, Sandostatin.
Payment limit per 25 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J2354
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Octreotide Acetate | Hikma Pharmaceuticals USA Inc. | 00641-6174-10 | 20 | $11.48 |
| Octreotide Acetate | Hikma Pharmaceuticals USA Inc. | 00641-6175-10 | 40 | $22.96 |
| Octreotide Acetate | Hikma Pharmaceuticals USA Inc. | 00641-6176-10 | 200 | $114.80 |
| Octreotide Acetate | Hikma Pharmaceuticals USA Inc. | 00641-6177-01 | 40 | $22.96 |
| Octreotide Acetate | Hikma Pharmaceuticals USA Inc. | 00641-6178-01 | 200 | $114.80 |
| Octreotide Acetate | Heritage Pharmaceuticals Inc. | 23155-0685-31 | 40 | $22.96 |
| Octreotide Acetate | Heritage Pharmaceuticals Inc. | 23155-0686-31 | 200 | $114.80 |
| Octreotide Acetate | Heritage Pharmaceuticals Inc. | 23155-0687-41 | 20 | $11.48 |
| Octreotide Acetate | Heritage Pharmaceuticals Inc. | 23155-0688-41 | 40 | $22.96 |
| Octreotide Acetate | Heritage Pharmaceuticals Inc. | 23155-0689-41 | 200 | $114.80 |
Show all 36 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0451-01 | 20 | $11.48 |
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0452-01 | 40 | $22.96 |
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0453-01 | 200 | $114.80 |
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0454-05 | 40 | $22.96 |
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0463-01 | 20 | $11.48 |
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0464-01 | 40 | $22.96 |
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0465-01 | 200 | $114.80 |
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0466-05 | 40 | $22.96 |
| Octreotide Acetate | Sagent Pharmaceuticals | 25021-0467-05 | 200 | $114.80 |
| Octreotide Acetate | FreseniUS Kabi USA, LLC | 63323-0376-01 | 40 | $22.96 |
| Octreotide Acetate | FreseniUS Kabi USA, LLC | 63323-0376-04 | 40 | $22.96 |
| Octreotide Acetate | FreseniUS Kabi USA, LLC | 63323-0377-01 | 200 | $114.80 |
| Octreotide Acetate | FreseniUS Kabi USA, LLC | 63323-0377-04 | 200 | $114.80 |
| Octreotide Acetate | FreseniUS Kabi USA, LLC | 63323-0378-05 | 40 | $22.96 |
| Octreotide Acetate | FreseniUS Kabi USA, LLC | 63323-0379-05 | 200 | $114.80 |
| Octreotide Acetate | Mylan Institutional LLC | 67457-0239-01 | 20 | $11.48 |
| Octreotide Acetate | Mylan Institutional LLC | 67457-0245-01 | 40 | $22.96 |
| Octreotide Acetate | Mylan Institutional LLC | 67457-0246-01 | 200 | $114.80 |
| Octreotide Acetate | Glenmark Pharmaceuticals Inc., USA | 68462-0896-10 | 40 | $22.96 |
| Octreotide Acetate | Glenmark Pharmaceuticals Inc., USA | 68462-0897-10 | 200 | $114.80 |
| Octreotide Acetate | Meitheal Pharmaceuticals Inc. | 71288-0566-02 | 20 | $11.48 |
| Octreotide Acetate | Meitheal Pharmaceuticals Inc. | 71288-0567-02 | 40 | $22.96 |
| Octreotide Acetate | Meitheal Pharmaceuticals Inc. | 71288-0568-02 | 200 | $114.80 |
| Sandostatin | Novartis Pharmaceuticals Corporation | 00078-0180-01 | 20 | $11.48 |
| Sandostatin | Novartis Pharmaceuticals Corporation | 00078-0181-01 | 40 | $22.96 |
| Sandostatin | Novartis Pharmaceuticals Corporation | 00078-0182-01 | 200 | $114.80 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.574 | −$0.022 | 25 MCG | Octreotide inj, non-depot | v1, posted September 17, 2026 |
| 3Q26 | $0.596 | −$0.028 | 25 MCG | Octreotide inj, non-depot | v1, posted September 15, 2026 |
| 2Q26 | $0.624 | −$0.034 | 25 MCG | Octreotide inj, non-depot | v1, posted September 15, 2026 |
| 1Q26 | $0.658 | +$0.048 | 25 MCG | Octreotide inj, non-depot | v1, posted September 15, 2026 |
| 4Q25 | $0.61 | +$0.004 | 25 MCG | Octreotide inj, non-depot | v1, posted September 8, 2026 |
| 3Q25 | $0.606 | +$0.016 | 25 MCG | Octreotide inj, non-depot | v1, posted March 10, 2026 |
| 2Q25 | $0.59 | −$0.215 | 25 MCG | Octreotide inj, non-depot | v1, posted March 10, 2026 |
| 1Q25 | $0.805 | −$0.058 | 25 MCG | Octreotide inj, non-depot | v1, posted December 19, 2025 |
| 4Q24 | $0.863 | −$0.04 | 25 MCG | Octreotide inj, non-depot | v1, posted June 11, 2025 |
| 3Q24 | $0.903 | −$0.219 | 25 MCG | Octreotide inj, non-depot | v1, posted June 11, 2025 |
| 2Q24 | $1.122 | −$0.066 | 25 MCG | Octreotide inj, non-depot | v1, posted March 11, 2025 |
| 1Q24 | $1.188 | +$0.072 | 25 MCG | Octreotide inj, non-depot | v1, posted December 19, 2024 |
| 4Q23 | $1.116 | −$0.198 | 25 MCG | Octreotide inj, non-depot | v1, posted October 10, 2024 |
| 3Q23 | $1.314 | +$0.155 | 25 MCG | Octreotide inj, non-depot | v1, posted June 5, 2024 |
| 2Q23 | $1.159 | −$0.262 | 25 MCG | Octreotide inj, non-depot | v1, posted February 23, 2024 |
| 1Q23 | $1.421 | +$0.304 | 25 MCG | Octreotide inj, non-depot | v1, posted December 6, 2023 |
| 4Q22 | $1.117 | +$0.301 | 25 MCG | Octreotide inj, non-depot | v1, posted June 22, 2023 |
| 3Q22 | $0.816 | −$0.03 | 25 MCG | Octreotide inj, non-depot | v1, posted June 9, 2023 |
| 2Q22 | $0.846 | −$0.123 | 25 MCG | Octreotide inj, non-depot | v1, posted December 14, 2022 |
| 1Q22 | $0.969 | +$0.024 | 25 MCG | Octreotide inj, non-depot | v1, posted June 8, 2022 |
| 4Q21 | $0.945 | −$0.094 | 25 MCG | Octreotide inj, non-depot | v1, posted June 2, 2022 |
| 3Q21 | $1.039 | +$0.013 | 25 MCG | Octreotide inj, non-depot | v1, posted June 2, 2022 |
| 2Q21 | $1.026 | +$0.289 | 25 MCG | Octreotide inj, non-depot | v1, posted March 1, 2022 |
| 1Q21 | $0.737 | – | 25 MCG | Octreotide inj, non-depot | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021